Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Working Capital Changes (2020 - 2025)

Maravai Lifesciences Holdings has reported Other Working Capital Changes over the past 6 years, most recently at $264000.0 for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $264000.0 for Q4 2025, down 92.09% from a year ago — trailing twelve months through Dec 2025 was -$181000.0 (up 90.02% YoY), and the annual figure for FY2025 was -$181000.0, up 90.02%.
  • Other Working Capital Changes for Q4 2025 was $264000.0 at Maravai Lifesciences Holdings, down from $290000.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for MRVI hit a ceiling of $26.3 million in Q3 2022 and a floor of -$32.5 million in Q4 2022.
  • Median Other Working Capital Changes over the past 5 years was -$195000.0 (2023), compared with a mean of $203650.0.
  • Peak annual rise in Other Working Capital Changes hit 2335.09% in 2021, while the deepest fall reached 17187.5% in 2021.
  • Maravai Lifesciences Holdings' Other Working Capital Changes stood at $20.9 million in 2021, then crashed by 256.03% to -$32.5 million in 2022, then surged by 79.36% to -$6.7 million in 2023, then skyrocketed by 149.67% to $3.3 million in 2024, then tumbled by 92.09% to $264000.0 in 2025.
  • The last three reported values for Other Working Capital Changes were $264000.0 (Q4 2025), $290000.0 (Q3 2025), and $7.8 million (Q2 2025) per Business Quant data.